1. Home
  2. Browse
  3. National Institutes of Health
  4. PAR-25-442

Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)

Deadline
2027-02-17
167 days left
Award ceiling
Awards
Posted
2025-06-17

Summary

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications for exploratory and early-stage projects that focus on undruggable target classes (targets that cannot be engaged with high affinity through conventional means) within intractable human disease. […]

The rest of this announcement — free with an account

  • The full announcement text, not the first two sentences
  • All 3 review criteria reviewers score this against, extracted from this announcement
  • Whether you are eligible — career stage, institution type, and the windows that close before the deadline does
  • What similar funded projects received, from 219,000 past awards

No card required. Browsing and your first match are free.

More from National Institutes of Health

See all →

Official announcement: https://grants.nih.gov/grants/guide/pa-files/PAR-25-442.htmlSource: nih_guide+grants_gov. Always confirm dates with the funder.